T cell-depleted cultured pediatric thymus tissue as a model for some aspects of human age-related thymus involution.

Aging CCL21 CXCL12 CXCL16 L-selectin Thymus involution Thymus organ cultures Thymus transplantation

Journal

GeroScience
ISSN: 2509-2723
Titre abrégé: Geroscience
Pays: Switzerland
ID NLM: 101686284

Informations de publication

Date de publication:
06 2021
Historique:
received: 21 07 2020
accepted: 16 11 2020
pubmed: 10 1 2021
medline: 2 7 2021
entrez: 9 1 2021
Statut: ppublish

Résumé

Human age-related thymus involution is characterized by loss of developing thymocytes and the thymic epithelial network that supports them, with replacement by adipose tissue. The mechanisms that drive these changes are difficult to study in vivo due to constant trafficking to and from the thymus. We hypothesized that the loss of thymocytes that occurs during human thymic organ cultures could model some aspects of thymus involution and begin to identify mechanisms that drive age-related changes in the thymic microenvironment. Potential mechanistically important candidate molecules were initially identified by screening conditioned media from human thymus organ cultures using antibody microarrays. These candidates were further validated using cultured tissue extracts and conditioned media. Results were compared with gene expression studies from a panel of well-characterized (non-cultured) human thymus tissues from human donors aged 5 days to 78 years. L-selectin released into conditioned media was identified as a biomarker for the content of viable thymocytes within the cultured thymus. Levels of the chemokines CCL21 and CXCL12, likely produced by surviving thymic epithelial cells, increased markedly in conditioned media as thymocytes were lost during culture. Native non-cultured thymus from adults older than 18 years also showed a strong trend toward increased CCL21 expression, in conjunction with significant decreases in thymocyte-related mRNAs compared with thymus from subjects younger than 18 years. Together, these findings demonstrate that use of postnatal human thymus organ cultures can model some aspects of human age-related thymic involution.

Identifiants

pubmed: 33420705
doi: 10.1007/s11357-020-00301-1
pii: 10.1007/s11357-020-00301-1
pmc: PMC8190428
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1369-1382

Subventions

Organisme : NIAID NIH HHS
ID : UC6 AI058607
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI047040
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI139449
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG007672
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG052359
Pays : United States

Références

Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol. 2007;211:144–56. https://doi.org/10.1002/path.2104 .
doi: 10.1002/path.2104 pubmed: 17200946 pmcid: 1931833
Palmer S, Albergante L, Blackburn CC, Newman TJ. Thymic involution and rising disease incidence with age. Proc Natl Acad Sci U S A. 2018;115:1883–8. https://doi.org/10.1073/pnas.1714478115 .
doi: 10.1073/pnas.1714478115 pubmed: 29432166 pmcid: 5828591
Sun DP, et al. Thymic hyperplasia after chemotherapy in adults with mature B cell lymphoma and its influence on thymic output and CD4(+) T cells repopulation. Oncoimmunology. 2016;5:e1137417. https://doi.org/10.1080/2162402X.2015.1137417 .
doi: 10.1080/2162402X.2015.1137417 pubmed: 27467956 pmcid: 4910735
Wickemeyer JL, Sekhsaria S. Prolonged severe immunodeficiency following thymectomy and radiation: a case report. J Med Case Rep. 2014;8:457. https://doi.org/10.1186/1752-1947-8-457 .
doi: 10.1186/1752-1947-8-457 pubmed: 25528459 pmcid: 4307222
Markert ML, Watson TJ, Kaplan I, Hale LP, Haynes BF. The human thymic microenvironment during organ culture. Clin Immunol Immunopathol. 1997b;82:26–36.
doi: 10.1006/clin.1996.4266
Davies EG, et al. Thymus transplantation for complete DiGeorge syndrome: European experience. J Allergy Clin Immunol. 2017;140(1660-1670):e1616. https://doi.org/10.1016/j.jaci.2017.03.020 .
doi: 10.1016/j.jaci.2017.03.020
Davis CM, et al. Normalization of the peripheral blood T cell receptor V beta repertoire after cultured postnatal human thymic transplantation in DiGeorge syndrome. J Clin Immunol. 1997;17:167–75. https://doi.org/10.1023/a:1027382600143 .
doi: 10.1023/a:1027382600143 pubmed: 9083893
Markert ML, et al. Successful formation of a chimeric human thymus allograft following transplantation of cultured postnatal human thymus. J Immunol. 1997a;158:998–1005.
pubmed: 8993022
Markert ML, et al. Transplantation of thymus tissue in complete DiGeorge syndrome. N Engl J Med. 1999;341:1180–9. https://doi.org/10.1056/NEJM199910143411603 .
doi: 10.1056/NEJM199910143411603 pubmed: 10523153
Markert ML, et al. Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients. Blood. 2003;102:1121–30. https://doi.org/10.1182/blood-2002-08-2545 .
doi: 10.1182/blood-2002-08-2545 pubmed: 12702512
Markert ML, et al. Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome. Blood. 2004;104:2574–81. https://doi.org/10.1182/blood-2003-08-2984 .
doi: 10.1182/blood-2003-08-2984 pubmed: 15100156
Markert ML, et al. Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants. Blood. 2007;109:4539–47. https://doi.org/10.1182/blood-2006-10-048652 .
doi: 10.1182/blood-2006-10-048652 pubmed: 17284531 pmcid: 1885498
Markert ML, Devlin BH, McCarthy EA. Thymus transplantation. Clin Immunol. 2010;135:236–46. https://doi.org/10.1016/j.clim.2010.02.007 .
doi: 10.1016/j.clim.2010.02.007 pubmed: 20236866 pmcid: 3646264
Markert ML, et al. First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases. Blood. 2011;117:688–96. https://doi.org/10.1182/blood-2010-06-292490 .
doi: 10.1182/blood-2010-06-292490 pubmed: 20978268 pmcid: 3031487
Hu Z, Lancaster JN, Ehrlich LI. The contribution of chemokines and migration to the induction of central tolerance in the thymus. Front Immunol. 2015;6:398. https://doi.org/10.3389/fimmu.2015.00398 .
doi: 10.3389/fimmu.2015.00398 pubmed: 26300884 pmcid: 4528182
Lancaster JN, Li Y, Ehrlich LIR. Chemokine-mediated choreography of thymocyte development and selection trends. Immunol. 2018;39:86–98. https://doi.org/10.1016/j.it.2017.10.007 .
doi: 10.1016/j.it.2017.10.007
Bunting MD, Comerford I, McColl SR. Finding their niche: chemokines directing cell migration in the thymus. Immunol Cell Biol. 2011;89:185–96. https://doi.org/10.1038/icb.2010.142 .
doi: 10.1038/icb.2010.142 pubmed: 21135866
Liu C, et al. The role of CCL21 in recruitment of T-precursor cells to fetal thymi. Blood. 2005;105:31–9. https://doi.org/10.1182/blood-2004-04-1369 .
doi: 10.1182/blood-2004-04-1369 pubmed: 15358618
Lkhagvasuren E, Sakata M, Ohigashi I, Takahama Y. Lymphotoxin beta receptor regulates the development of CCL21-expressing subset of postnatal medullary thymic epithelial cells. J Immunol. 2013;190:5110–7. https://doi.org/10.4049/jimmunol.1203203 .
doi: 10.4049/jimmunol.1203203 pubmed: 23585674
Hong R, Moore AL. Organ culture for thymus transplantation. Transplantation. 1996;61:444–8. https://doi.org/10.1097/00007890-199602150-00023 .
doi: 10.1097/00007890-199602150-00023 pubmed: 8610359
Ito R, Hale LP, Geyer SM, Li J, Sornborger A, Kajimura J, et al. Late effects of exposure to ionizing radiation and age on human thymus morphology and function. Radiat Res. 2017;187:589–98. https://doi.org/10.1667/RR4554.1 .
doi: 10.1667/RR4554.1 pubmed: 28319462 pmcid: 5505072
Kuwabara I, Kuwabara Y, Yang RY, Schuler M, Green DR, Zuraw BL, et al. Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release. J Biol Chem. 2002;277:3487–97. https://doi.org/10.1074/jbc.M109360200 .
doi: 10.1074/jbc.M109360200 pubmed: 11706006
Biron-Pain K, Grosset AA, Poirier F, Gaboury L, St-Pierre Y. Expression and functions of galectin-7 in human and murine melanomas. PLoS One. 2013;8:e63307. https://doi.org/10.1371/journal.pone.0063307 .
doi: 10.1371/journal.pone.0063307 pubmed: 23658821 pmcid: 3643947
Le PT, Kurtzberg J, Brandt SJ, Niedel JE, Haynes BF, Singer KH. Human thymic epithelial cells produce granulocyte and macrophage colony-stimulating factors. J Immunol. 1988;141:1211–7.
pubmed: 2456345
Hafezi-Moghadam A, Thomas KL, Prorock AJ, Huo Y, Ley K. L-selectin shedding regulates leukocyte recruitment. J Exp Med. 2001;193:863–72. https://doi.org/10.1084/jem.193.7.863 .
doi: 10.1084/jem.193.7.863 pubmed: 11283159 pmcid: 2193368
Ivetic A, Hoskins Green HL, Hart SJ. L-selectin: a major regulator of leukocyte adhesion, migration and signaling. front. Immunol. 2019;10:1068. https://doi.org/10.3389/fimmu.2019.01068 .
doi: 10.3389/fimmu.2019.01068 pubmed: 31139190 pmcid: 6527602
Fitzhugh DJ, Shan S, Dewhirst MW, Hale LP. Bromelain treatment decreases neutrophil migration to sites of inflammation. Clin Immunol. 2008;128:66–74. https://doi.org/10.1016/j.clim.2008.02.015 .
doi: 10.1016/j.clim.2008.02.015 pubmed: 18482869 pmcid: 2516972
Kozai M, et al. Essential role of CCL21 in establishment of central self-tolerance in T cells. J Exp Med. 2017;214:1925–35. https://doi.org/10.1084/jem.20161864 .
doi: 10.1084/jem.20161864 pubmed: 28611158 pmcid: 5502431
Hale LP, Neff J, Cheatham L, Cardona D, Markert ML, Kurtzberg J. Histopathologic assessment of cultured human thymus. PLoS One. 2020;15:e0230668. https://doi.org/10.1371/journal.pone.0230668 .
doi: 10.1371/journal.pone.0230668 pubmed: 32208448 pmcid: 7093005
Dudal S, et al. Integrated pharmacokinetic, pharmacodynamic and immunogenicity profiling of an anti-CCL21 monoclonal antibody in cynomolgus monkeys. MAbs. 2015;7:829–37. https://doi.org/10.1080/19420862.2015.1060384 .
doi: 10.1080/19420862.2015.1060384 pubmed: 26230385 pmcid: 4622749
Hernandez-Lopez C, Varas A, Sacedon R, Jimenez E, Munoz JJ, Zapata AG, et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for early human T-cell development. Blood. 2002;99:546–54. https://doi.org/10.1182/blood.v99.2.546 .
doi: 10.1182/blood.v99.2.546 pubmed: 11781237
Zaitseva M, Kawamura T, Loomis R, Goldstein H, Blauvelt A, Golding H. Stromal-derived factor 1 expression in the human thymus. J Immunol. 2002;168:2609–17. https://doi.org/10.4049/jimmunol.168.6.2609 .
doi: 10.4049/jimmunol.168.6.2609 pubmed: 11884424
Weiss JM, Cufi P, Bismuth J, Eymard B, Fadel E, Berrih-Aknin S, et al. SDF-1/CXCL12 recruits B cells and antigen-presenting cells to the thymus of autoimmune myasthenia gravis patients. Immunobiology. 2013;218:373–81. https://doi.org/10.1016/j.imbio.2012.05.006 .
doi: 10.1016/j.imbio.2012.05.006 pubmed: 22704519
Flores KG, Li J, Sempowski GD, Haynes BF, Hale LP. Analysis of the human thymic perivascular space during aging. J Clin Invest. 1999;104:1031–9. https://doi.org/10.1172/JCI7558 .
doi: 10.1172/JCI7558 pubmed: 10525041 pmcid: 408578
Markert ML, et al. Use of allograft biopsies to assess thymopoiesis after thymus transplantation. J Immunol. 2008;180:6354–64. https://doi.org/10.4049/jimmunol.180.9.6354 .
doi: 10.4049/jimmunol.180.9.6354 pubmed: 18424759

Auteurs

Laura P Hale (LP)

Department of Pathology, Duke University School of Medicine, Durham, NC, USA. laura.hale@duke.edu.
Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA. laura.hale@duke.edu.

Lynn Cheatham (L)

Marcus Center for Cellular Cures, Duke University School of Medicine, Durham, NC, USA.

Andrew N Macintyre (AN)

Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Department of Medicine, Duke University School of Medicine, Durham, NC, USA.

Bonnie LaFleur (B)

The BIO5 Institute, University of Arizona, Tucson, AZ, USA.

Brittany Sanders (B)

Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.

Jesse Troy (J)

Marcus Center for Cellular Cures, Duke University School of Medicine, Durham, NC, USA.

Joanne Kurtzberg (J)

Marcus Center for Cellular Cures, Duke University School of Medicine, Durham, NC, USA.
Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.

Gregory D Sempowski (GD)

Department of Pathology, Duke University School of Medicine, Durham, NC, USA.
Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Department of Medicine, Duke University School of Medicine, Durham, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH